Bottom line
FBTAX vs BIPIX: the short answer
FBTAX (Fidelity Advisor Biotechnology Fund) and BIPIX (Biotechnology Ultrasector Profund) are quite different portfolios: only about 16% of their top holdings (by weight) are shared.
FBTAX is cheaper at 0.94% vs 1.52% — a difference of $58 a year per $10,000 invested.
Over five years, FBTAX returned +6.4% a year vs +6.1% for BIPIX (reporting dates differ).
Updated Nov 19, 2026
FBTAX vs BIPIX side by side
| FBTAX | BIPIX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Fidelity | ProShares |
| Category | Technology Sector | Technology Sector |
| Expense ratio | 0.94% | 1.52% |
| Annual cost per $10k | $94 | $152 |
| 10-yr cost on $10k (prospectus) | $1,663 | $1,813 |
| Max front load | — | — |
| 12b-1 fee | 0.25% | 0% |
| 1-yr return | +31.5% | −5.2% |
| 5-yr return (annualized) | +6.4% | +6.1% |
| 10-yr return (annualized) | +7.7% | +4.4% |
| Best quarter | +30.3% | +35.4% |
| Worst quarter | −27.8% | −24.1% |
| Net assets (fund) | $2.2B | $118.7M |
| Number of holdings | 129 | 159 |
| Portfolio turnover | 54% | 52% |
| Returns as of | Sep 30, 2026 | Dec 31, 2024 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | FBTAX | BIPIX | Difference |
|---|---|---|---|
| 2024 | +5.3% | −5.2% | +10.6% |
| 2023 | +10.7% | +10.1% | +0.6% |
| 2022 | −8.0% | −13.4% | +5.5% |
| 2021 | −3.6% | +23.8% | −27.4% |
| 2020 | +32.2% | +20.1% | +12.1% |
| 2019 | +25.7% | +23.6% | +2.1% |
| 2018 | −3.8% | −12.2% | +8.4% |
| 2017 | +25.8% | +34.7% | −8.9% |
| 2016 | −23.6% | −23.8% | +0.2% |
| 2015 | +11.1% | +3.1% | +8.0% |
Source: Fund prospectus bar charts
Holdings overlap
7 of FBTAX's top 25 holdings also appear in BIPIX's top 25.
| Holding | FBTAX | BIPIX |
|---|---|---|
| Spyre Therapeutics Inc | 3.83% | 1.04% |
| Dianthus Therapeutics Inc | 3.55% | 1.12% |
| Cogent Biosciences Inc | 3.25% | 0.99% |
| Oruka Therapeutics Inc | 3.24% | 1.20% |
| Revolution Medicines Inc | 3.00% | 1.04% |
| Relay Therapeutics Inc | 1.58% | 0.95% |
| Natera Inc | 1.43% | 0.99% |
Source: SEC Form N-PORT
FBTAX top 10
- Abbvie Inc — 14.71%
- Gilead Sciences Inc — 5.70%
- Spyre Therapeutics Inc — 3.83%
- Alnylam Pharmaceuticals Inc — 3.62%
- Dianthus Therapeutics Inc — 3.55%
- Cogent Biosciences Inc — 3.25%
- Oruka Therapeutics Inc — 3.24%
- Insmed Inc — 3.05%
- Revolution Medicines Inc — 3.00%
- Argenx Se — 3.00%
BIPIX top 10
- N/a — 6.70%
- N/a — 5.15%
- N/a — 4.12%
- N/a — 4.12%
- N/a — 3.16%
- Agpxx — 2.40%
- Apogee Therapeutics Inc — 1.29%
- N/a — 1.24%
- Oruka Therapeutics Inc — 1.20%
- Dianthus Therapeutics Inc — 1.12%
FAQ
What is the difference between FBTAX and BIPIX?
Which is cheaper, FBTAX or BIPIX?
Should I own both FBTAX and BIPIX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.